Standard

Integrative group psychotherapy reduces daily cortisol output and hair cortisol: A randomized active‑controlled trial with multi‑day profiling. / Pokushalov, Evgeny; Terebenin, Evgeny; Ponomarenko, Andrey et al.

In: PLoS ONE, Vol. 21, No. 7, e0352095, 07.2026.

Research output: Contribution to journalArticlepeer-review

Harvard

Pokushalov, E, Terebenin, E, Ponomarenko, A, Sinyuk, Y, Samoilov, A, Gigovskaya, T, Bubnovskaya, M, Kudlay, D, Trubicina, E, Garcia, C & Miller, R 2026, 'Integrative group psychotherapy reduces daily cortisol output and hair cortisol: A randomized active‑controlled trial with multi‑day profiling', PLoS ONE, vol. 21, no. 7, e0352095. https://doi.org/10.1371/journal.pone.0352095

APA

Pokushalov, E., Terebenin, E., Ponomarenko, A., Sinyuk, Y., Samoilov, A., Gigovskaya, T., Bubnovskaya, M., Kudlay, D., Trubicina, E., Garcia, C., & Miller, R. (2026). Integrative group psychotherapy reduces daily cortisol output and hair cortisol: A randomized active‑controlled trial with multi‑day profiling. PLoS ONE, 21(7), [e0352095]. https://doi.org/10.1371/journal.pone.0352095

Vancouver

Pokushalov E, Terebenin E, Ponomarenko A, Sinyuk Y, Samoilov A, Gigovskaya T et al. Integrative group psychotherapy reduces daily cortisol output and hair cortisol: A randomized active‑controlled trial with multi‑day profiling. PLoS ONE. 2026 Jul;21(7):e0352095. doi: 10.1371/journal.pone.0352095

Author

Pokushalov, Evgeny ; Terebenin, Evgeny ; Ponomarenko, Andrey et al. / Integrative group psychotherapy reduces daily cortisol output and hair cortisol: A randomized active‑controlled trial with multi‑day profiling. In: PLoS ONE. 2026 ; Vol. 21, No. 7.

BibTeX

@article{e41df43f6ecb4574879386c7e567c6bb,
title = "Integrative group psychotherapy reduces daily cortisol output and hair cortisol: A randomized active‑controlled trial with multi‑day profiling",
abstract = "BACKGROUND: Chronic psychosocial stress can disrupt hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system function, yet randomized trials rarely combine multi-day diurnal salivary profiling with hair glucocorticoid assessment. METHODS: We conducted a parallel-group, superiority randomized controlled trial with 1:1 allocation to compare an 8-week integrative group program with a dose-matched active control. The intervention combined social-affective skills training, slow breathing with heart-rate-variability biofeedback, and cognitive reappraisal. The primary outcome was the change from baseline (T0) to end of treatment (T1) in daily salivary cortisol output, measured as the area under the curve with respect to ground (AUCg) from 3-day profiles. Key secondary outcomes were the cortisol awakening response, diurnal cortisol slope, salivary cortisone AUCg, salivary alpha-amylase AUCg, and hair cortisol concentration assessed from proximal 1-cm hair segments collected at the end of treatment and at the 6-month follow-up visit, with each segment indexing approximately the month immediately preceding collection. Outcomes were analyzed using intention-to-treat mixed-effects models with false-discovery-rate correction for secondary outcome families. RESULTS: Sixty participants were randomized to the intervention group (n = 30) or the control group (n = 30). The intervention reduced daily cortisol AUCg more than control from T0 to T1 (between-group difference in change, -21.91 nmol/L·h; 95% CI, -25.87 to -17.95), and this reduction was maintained at T2. Salivary cortisone AUCg and salivary alpha-amylase AUCg also decreased more in the intervention group. Hair cortisol concentration was lower in the proximal 1-cm segments collected at the end of treatment and at the 6-month follow-up visit. Trier Social Stress Test peak cortisol and baseline-corrected AUCi reactivity within the collected -1 to +30 min window did not differ significantly between groups. Adverse events were infrequent and similar between groups. LIMITATIONS: The trial was conducted at a single site, and the Trier Social Stress Test subsample was modest. CONCLUSIONS: An 8-week multicomponent group program reduced daily HPA-axis output and proximal-segment hair cortisol under active-control conditions. TRIAL REGISTRATION: ClinicalTrials.gov NCT06863948 (registered 07 Mar 2025).",
author = "Evgeny Pokushalov and Evgeny Terebenin and Andrey Ponomarenko and Yulia Sinyuk and Alexander Samoilov and Tatiana Gigovskaya and Marina Bubnovskaya and Dmitry Kudlay and Elena Trubicina and Claire Garcia and Richard Miller",
note = "This work was supported by an unrestricted grant from Therapy of the Soul (NovosibirsThis work was supported by an unrestricted grant from Therapy of the Soul (Novosibirsk, Russian Federation) awarded to the Center for New Medical Technologies (Novosibirsk, Russian Federation) to support intervention delivery and study operations as specified in the protocol. The funder provided support in the form of salaries for authors Y.S., A.S., T.G., and M.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the {\textquoteleft}Author Contributions{\textquoteright} section. Triangel Scientific (San Francisco, USA) did not receive the study grant; it provided support in the form of salaries for authors E.P., C.G., and R.M. and contributed to protocol finalization and independent data processing/statistical analyses as described in the {\textquoteleft}Author Contributions{\textquoteright} section. There was no additional external funding received for this study.k, Russian Federation) awarded to the Center for New Medical Technologies (Novosibirsk) to support intervention delivery and study operations as specified in the protocol.",
year = "2026",
month = jul,
doi = "10.1371/journal.pone.0352095",
language = "English",
volume = "21",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

RIS

TY - JOUR

T1 - Integrative group psychotherapy reduces daily cortisol output and hair cortisol: A randomized active‑controlled trial with multi‑day profiling

AU - Pokushalov, Evgeny

AU - Terebenin, Evgeny

AU - Ponomarenko, Andrey

AU - Sinyuk, Yulia

AU - Samoilov, Alexander

AU - Gigovskaya, Tatiana

AU - Bubnovskaya, Marina

AU - Kudlay, Dmitry

AU - Trubicina, Elena

AU - Garcia, Claire

AU - Miller, Richard

N1 - This work was supported by an unrestricted grant from Therapy of the Soul (NovosibirsThis work was supported by an unrestricted grant from Therapy of the Soul (Novosibirsk, Russian Federation) awarded to the Center for New Medical Technologies (Novosibirsk, Russian Federation) to support intervention delivery and study operations as specified in the protocol. The funder provided support in the form of salaries for authors Y.S., A.S., T.G., and M.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘Author Contributions’ section. Triangel Scientific (San Francisco, USA) did not receive the study grant; it provided support in the form of salaries for authors E.P., C.G., and R.M. and contributed to protocol finalization and independent data processing/statistical analyses as described in the ‘Author Contributions’ section. There was no additional external funding received for this study.k, Russian Federation) awarded to the Center for New Medical Technologies (Novosibirsk) to support intervention delivery and study operations as specified in the protocol.

PY - 2026/7

Y1 - 2026/7

N2 - BACKGROUND: Chronic psychosocial stress can disrupt hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system function, yet randomized trials rarely combine multi-day diurnal salivary profiling with hair glucocorticoid assessment. METHODS: We conducted a parallel-group, superiority randomized controlled trial with 1:1 allocation to compare an 8-week integrative group program with a dose-matched active control. The intervention combined social-affective skills training, slow breathing with heart-rate-variability biofeedback, and cognitive reappraisal. The primary outcome was the change from baseline (T0) to end of treatment (T1) in daily salivary cortisol output, measured as the area under the curve with respect to ground (AUCg) from 3-day profiles. Key secondary outcomes were the cortisol awakening response, diurnal cortisol slope, salivary cortisone AUCg, salivary alpha-amylase AUCg, and hair cortisol concentration assessed from proximal 1-cm hair segments collected at the end of treatment and at the 6-month follow-up visit, with each segment indexing approximately the month immediately preceding collection. Outcomes were analyzed using intention-to-treat mixed-effects models with false-discovery-rate correction for secondary outcome families. RESULTS: Sixty participants were randomized to the intervention group (n = 30) or the control group (n = 30). The intervention reduced daily cortisol AUCg more than control from T0 to T1 (between-group difference in change, -21.91 nmol/L·h; 95% CI, -25.87 to -17.95), and this reduction was maintained at T2. Salivary cortisone AUCg and salivary alpha-amylase AUCg also decreased more in the intervention group. Hair cortisol concentration was lower in the proximal 1-cm segments collected at the end of treatment and at the 6-month follow-up visit. Trier Social Stress Test peak cortisol and baseline-corrected AUCi reactivity within the collected -1 to +30 min window did not differ significantly between groups. Adverse events were infrequent and similar between groups. LIMITATIONS: The trial was conducted at a single site, and the Trier Social Stress Test subsample was modest. CONCLUSIONS: An 8-week multicomponent group program reduced daily HPA-axis output and proximal-segment hair cortisol under active-control conditions. TRIAL REGISTRATION: ClinicalTrials.gov NCT06863948 (registered 07 Mar 2025).

AB - BACKGROUND: Chronic psychosocial stress can disrupt hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system function, yet randomized trials rarely combine multi-day diurnal salivary profiling with hair glucocorticoid assessment. METHODS: We conducted a parallel-group, superiority randomized controlled trial with 1:1 allocation to compare an 8-week integrative group program with a dose-matched active control. The intervention combined social-affective skills training, slow breathing with heart-rate-variability biofeedback, and cognitive reappraisal. The primary outcome was the change from baseline (T0) to end of treatment (T1) in daily salivary cortisol output, measured as the area under the curve with respect to ground (AUCg) from 3-day profiles. Key secondary outcomes were the cortisol awakening response, diurnal cortisol slope, salivary cortisone AUCg, salivary alpha-amylase AUCg, and hair cortisol concentration assessed from proximal 1-cm hair segments collected at the end of treatment and at the 6-month follow-up visit, with each segment indexing approximately the month immediately preceding collection. Outcomes were analyzed using intention-to-treat mixed-effects models with false-discovery-rate correction for secondary outcome families. RESULTS: Sixty participants were randomized to the intervention group (n = 30) or the control group (n = 30). The intervention reduced daily cortisol AUCg more than control from T0 to T1 (between-group difference in change, -21.91 nmol/L·h; 95% CI, -25.87 to -17.95), and this reduction was maintained at T2. Salivary cortisone AUCg and salivary alpha-amylase AUCg also decreased more in the intervention group. Hair cortisol concentration was lower in the proximal 1-cm segments collected at the end of treatment and at the 6-month follow-up visit. Trier Social Stress Test peak cortisol and baseline-corrected AUCi reactivity within the collected -1 to +30 min window did not differ significantly between groups. Adverse events were infrequent and similar between groups. LIMITATIONS: The trial was conducted at a single site, and the Trier Social Stress Test subsample was modest. CONCLUSIONS: An 8-week multicomponent group program reduced daily HPA-axis output and proximal-segment hair cortisol under active-control conditions. TRIAL REGISTRATION: ClinicalTrials.gov NCT06863948 (registered 07 Mar 2025).

UR - https://www.scopus.com/pages/publications/105046076540

UR - https://www.mendeley.com/catalogue/a0afa154-260e-344e-8b7c-042327386a45/

U2 - 10.1371/journal.pone.0352095

DO - 10.1371/journal.pone.0352095

M3 - Article

C2 - 42490633

VL - 21

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 7

M1 - e0352095

ER -

ID: 81293669